Junín virus (JUNV) entry is conducted by receptor-mediated endocytosis. To explore the cellular entry mechanism of JUNV, inhibitory effects of drugs affecting the main endocytic pathways on JUNV entry into Vero cells were analysed. Compounds that impair clathrin-mediated endocytosis were shown to reduce virus internalization without affecting virion binding. In contrast, drugs that alter lipid-raft microdomains, impairing caveola-mediated endocytosis, were not able to block virus entry. To show direct evidence of JUNV entry, transmission electron microscopy was performed; it showed JUNV particles of about 60-100 nm in membrane depressions that had an electron-dense coating. In addition, JUNV particles were found within invaginations of the plasma membrane and vesicles that resembled those of pits and clathrin-coated vesicles. Taken together, these results demonstrate that clathrin-mediated endocytosis is the main JUNV entry pathway into Vero cells and represent an important contribution to the characterization of the arenavirus multiplication cycle.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1099/vir.0.82808-0 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A hTfR1 Receptor-Specific VHH Antibody Neutralizes Pseudoviruses Expressing Glycoproteins from Junín and Machupo Viruses.
Viruses
December 2024
School of Medicine, Zhejiang University, Hangzhou 310063, China.
The Junín virus (JUNV) is one of the New World arenaviruses that cause severe hemorrhagic fever. Human transferrin receptor 1 (hTfR1) has been identified as the main receptor for JUNV for virus entry into host cells. To date, no treatment has been approved for JUNV.
View Article and Find Full Text PDFCellular N-Myristoyl Transferases Are Required for Mammarenavirus Multiplication.
Viruses
August 2024
Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
The mammarenavirus matrix Z protein plays critical roles in virus assembly and cell egress. Meanwhile, heterotrimer complexes of a stable signal peptide (SSP) together with glycoprotein subunits GP1 and GP2, generated via co-and post-translational processing of the surface glycoprotein precursor GPC, form the spikes that decorate the virion surface and mediate virus cell entry via receptor-mediated endocytosis. The Z protein and the SSP undergo N-terminal myristoylation by host cell N-myristoyltransferases (NMT1 and NMT2), and G2A mutations that prevent myristoylation of Z or SSP have been shown to affect the Z-mediated virus budding and GP2-mediated fusion activity that is required to complete the virus cell entry process.
View Article and Find Full Text PDFArticle Synopsis
- - The Z protein of mammarenaviruses is crucial for virus assembly and exiting host cells, while glycoproteins GP1 and GP2, linked by a stable signal peptide, form spikes that help the virus enter host cells.
- - Myristoylation, a modification performed by host cell enzymes, is essential for the function of both the Z protein and the stable signal peptide, with mutations that block this process negatively impacting virus budding and fusion.
- - The study reveals that the NMT inhibitor DDD85464 shows strong antiviral effects against various mammarenaviruses, including LCMV, JUNV, and LASV, by disrupting Z protein activity and reducing viral entry processes.
Effects of the Natural Flavonoid Quercetin on Arenavirus Junín Infection.
Viruses
August 2023
Laboratory of Antiviral Strategies, Biochemistry Department, School of Sciences, University of Buenos Aires, IQUIBICEN, University of Buenos Aires/Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires 1428, Argentina.
There is no specific chemotherapy approved for the treatment of pathogenic arenaviruses that cause severe hemorrhagic fever (HF) in the population of endemic regions in America and Africa. The present study reports the effects of the natural flavonoid quercetin (QUER) on the infection of A549 and Vero cells with Junín virus (JUNV), agent of the Argentine HF. By infectivity assays, a very effective dose-dependent reduction of JUNV multiplication was shown by cell pretreatment at 2-6 h prior to the infection at non-cytotoxic concentrations, with 50% effective concentration values in the range of 6.
View Article and Find Full Text PDFSevere mammarenaviral disease in guinea pigs effectively treated by an orally bioavailable fusion inhibitor, alone or in combination with favipiravir.
Antiviral Res
December 2022
Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT, USA. Electronic address:
Article Synopsis
- Infections from New World mammarenaviruses, like Junín virus, cause serious viral hemorrhagic fever and currently lack FDA-approved treatments, classifying them as high-priority pathogens.
- ARN-75039 is a powerful fusion inhibitor that has shown effectiveness against various mammarenaviruses in laboratory settings and provides protection in guinea pigs even after delayed treatment following viral exposure.
- The study also indicates that combining ARN-75039 with favipiravir enhances treatment effectiveness and improves survival rates in infected guinea pigs, supporting its potential as a therapeutic option for these infections.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!